Clinical research blog

Precision medicine represents a fundamental shift in how therapies are developed and delivered. Rather than designing treatments for the average patient, it tak...

This webinar, hosted by Patrick Short, CEO of Sano Genetics, and featuring Dr. Mark Kotter, CEO of bit.bio, focused on precision medicine in multiple sclerosis....

This webinar was hosted by Sano Genetics' scientific advisor, Paul Wicks, and featured representatives from Genomics England as well as Sage Bionetworks. The di...

Sano raises $11 million in Series A funding round led by MMC Ventures New funding will support the team to grow and further its mission to accelerate personalis...

If you missed our webinar, you can catch up on an exciting discussion about the future of precision medicine research in multiple sclerosis here on our blog.

Advances in large-scale genome sequencing, data storage, and analysis are accelerating the development of precision medicine across a growing number of therapeu...

Polygenic risk scores enable clinicians and researchers to stratify patient populations by genetic risk, informing decisions on screening schedules, therapeutic...

Clinical trials increasingly depend on genomic data to identify the right patients, reduce variability in treatment response, and accelerate the path to approva...